PM reportedly not in favor of compelling citizens to be inoculated against coronavirus, but discussions said ongoing as to whether public officials can be required to have shot

PM says talks in final stages to supply vaccine developed by University of Oxford, which has been shown to produce fewer side effects in elderly; would be Israel's 3rd deal

FDA says Oxford vaccine testing can resume; other nations already determined participant's illness not related; J&J also finds no link to subject's illness in its trial

Death marks first known fatality in worldwide vaccine trials, independent review concludes no safety concerns and testing can continue

Berlin's foreign minister reportedly told Israeli counterpart Jewish state would enjoy AstraZeneca COVID-19 inoculation sold to European countries

AstraZeneca and Oxford University say they got they all clear to continue inoculations after trials were briefly halted because volunteer became sick

Experts say pausing of phase 3 trials for top vaccine candidate after volunteer develops unexplained illness is 'a totally reasonable measure of caution' -- but markets are spooked

Company investigating if a recipient’s 'potentially unexplained' illness is a side effect of shot, calls move 'standard review process,' in late-stage studies being conducted

AstraZeneca treatment to begin trials on tens of thousands; US advisory panel releases draft plan for rationing a successful vaccine, with healthcare workers first in line

No details published, but Health Ministry source says no action now would mean waiting a year or more once vaccine is available